Sleep-disordered breathing in hypertrophic cardiomyopathy: challenges and opportunities.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25010966.
- Also identified by DOI 10.1378/chest.14-0084 and PMC identifier 4077409.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sleep-disordered breathing (SDB) may be a treatable risk factor in patients with hypertrophic cardiomyopathy (HCM), the most common inherited cardiomyopathy. Evidence suggests a high prevalence of SDB in HCM. We summarize the pathophysiology of SDB as it relates to hypertension, coronary artery disease, atrial fibrillation, and sudden cardiac death in patients with HCM. The implications regarding the care of patients with HCM and SDB are discussed as well as the knowledge deficits needing further exploration.
Medical subject headings
- Cardiomyopathy, Hypertrophic
- Disease Management
- Sleep Apnea Syndromes